WARNING: RISK FOR SERIOUS HYPERSENSITIVITY/ANAPHYLAXIS REACTIONS
Fatal and serious hypersensitivity reactions including anaphylaxis have occurred in patients receiving Feraheme. Initial symptoms may include hypotension, syncope, unresponsiveness, cardiac/cardiorespiratory arrest.
GFR is a diagnostic criterion for CKD.
Click here to estimate your patients’ GFR using the National Kidney Foundation’s online calculator tool.
IV drip calculator
Intravenous fluid must be given at a specific rate, neither too fast nor too slow. The specific rate may be measured as mL/hour, L/hour, or drops/min. To control or adjust the flow rate, only drops per minute are used.
To learn more, please click here.
Intravenous sets: tubing calibration
There are primarily 2 types of IV tubing sets:
- Macrodrip sets deliver 10, 15, or 20 drops per mL (gtt/mL)
- Microdrip sets deliver 60 gtt/mL
The infusion rate of Feraheme can be controlled using commercially available IV tubing. The drip rate can be calculated using number of drops per mL, which is available on the IV tubing packaging.
You are about to leave www.feraheme.com. If you select OK, you will be directed to another site. This is an external website, and we are not responsible for its content. Select OK to continue or Cancel to remain on this page.
WARNING: RISK FOR SERIOUS HYPERSENSITIVITY/ANAPHYLAXIS REACTIONSFatal and serious hypersensitivity reactions including anaphylaxis have occurred in patients receiving Feraheme. Initial symptoms may include hypotension, syncope, unresponsiveness, cardiac/cardiorespiratory arrest.
- Only administer Feraheme as an intravenous infusion over at least 15 minutes and only when personnel and therapies are immediately available for the treatment of anaphylaxis and other hypersensitivity reactions.
- Observe for signs or symptoms of hypersensitivity reactions during and for at least 30 minutes following Feraheme infusion including monitoring of blood pressure and pulse during and after Feraheme administration.
- Hypersensitivity reactions have occurred in patients in whom a previous Feraheme dose was tolerated.
Feraheme is indicated for the treatment of iron deficiency anemia (IDA) in adult patients:
- who have intolerance to oral iron or have had unsatisfactory response to oral iron or
- who have chronic kidney disease (CKD).